RALEIGH, N.C., March 16, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced three data presentations from research surrounding BELBUCA ® (buprenorphine) buccal film ...
DUBLIN, Feb. 22, 2016 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), today announced the availability of BELBUCA™ (buprenorphine) buccal ...
BioDelivery Science reclaimed Belbuca, which could have created operational problems for the small company. Based on early results, the company continues to sell prescriptions at the same rate as ENDP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results